학술논문
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Document Type
Article
Author
Source
In Lancet Oncology May 2012 13(5):539-548
Subject
Language
ISSN
1470-2045